BeStock  
Stocks › Biotechnology › SMMT

Summit Therapeutics SMMT

US equityMarket cap rank #1601BiotechnologyTop Gainers Yesterday
$9.95 −$0.62 (-5.87%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $10.08 +1.31%
Open$10.28
Prev close$10.57
Day range$9.89 – $10.61
Volume7.22M
Market cap$7.96B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$214.61M+8.4% YoY
Net profit-$208.39M+10.1% YoY
Diluted EPS-$0.26+16.1% YoY
Free cash flow-$160.21M-72.0% YoY
Operating cash flow-$159.81M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-61.2MDec '24$-62.9MMar '25$-565.7MJun '25$-231.8MSep '25$-219.1MDec '25$-189.4MMar '26$-215.7MJun '26$-208.4MSep '26

Diluted EPS by quarter

-0.09Dec '24-0.09Mar '25-0.76Jun '25-0.31Sep '25-0.29Dec '25-0.24Mar '26-0.28Jun '26-0.26Sep '26

Free cash flow by quarter

$-48.7MDec '24$-61.6MMar '25$-66.7MJun '25$-93.2MSep '25$-102.1MDec '25$-122.5MMar '26$-142.0MJun '26$-160.2MSep '26

Annual revenue

$860.0KFY20$1.8MFY21$705.0KFY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-220.0%
Return on assets-174.5%
Return on invested capital-212.9%
Current ratio5.99
Liabilities / assets18.5%
Cash & investments$629.79M
Total debt$16.13M
Net cash (debt)$613.65M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $214.61M $220.50M $195.21M $1.09B $224.88M
Selling and Admin Expenses $45.48M $62.76M $62.59M $556.70M $77.58M
-General & Admin Expense $45.48M $62.76M $62.59M $556.70M $77.58M
Research & Development $169.13M $157.73M $132.62M $537.67M $147.29M
Operating Profit -$214.61M -$220.50M -$195.21M -$1.09B -$224.88M
Other Income (Expense) $6.23M $4.80M $5.79M $14.84M $5.75M
Gain on Sale of Security $6.23M $4.30M $5.79M $14.89M $5.75M
Pretax Profit -$208.39M -$215.70M -$189.42M -$1.08B -$219.12M
Net Profit -$208.39M -$215.70M -$189.42M -$1.08B -$219.12M
Profit from Continuing Operations -$208.39M -$215.70M -$189.42M -$1.08B -$219.12M
Net Income to Parent Company -$208.39M -$215.70M -$189.42M -$1.08B -$219.17M
Net Income to Common Stockholders -$208.39M -$215.70M -$189.42M -$1.08B -$219.17M
Basic EPS -$0.26 -$0.28 -$0.24 -$1.44 -$0.29
Diluted EPS -$0.26 -$0.28 -$0.24 -$1.44 -$0.29
Other Non-Operating Income (Expenses) – $500,000.00 – -$53,000.00 $0.00
Net Non-Operating Interest Income (Expense) – – – $0.00 $0.00
Non-Operating Interest Expense – – – $0.00 $0.00
Special Income (Charges) – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $692.85M $752.19M $647.86M $751.18M $751.18M
Total Current Assets $660.73M $720.58M $616.60M $720.30M $720.30M
Cash and Cash Equivalents & Short-Term Investments $629.79M $690.68M $598.73M $713.45M $713.45M
-Cash and Cash Equivalents $150.81M $419.37M $106.52M $225.27M $225.27M
-Short Term Investments $478.98M $271.31M $492.22M $488.18M $488.18M
Restricted Cash $316,000.00 $317,000.00 $316,000.00 $316,000.00 $316,000.00
Other Current Assets $30.63M $29.58M $17.55M $6.54M $6.54M
Total Non-Current Assets $32.12M $31.61M $31.26M $30.88M $30.88M
Net PPE $21.19M $21.19M $21.06M $21.68M $21.68M
-Gross PPE $21.19M $21.19M $21.06M $21.68M $21.68M
Goodwill and Other Intangible Assets $1.98M $1.97M $1.97M $2.00M $2.00M
-Goodwill $1.98M $1.97M $1.97M $2.00M $2.00M
Other Non-Current Assets $8.96M $8.45M $8.23M $7.21M $7.21M
Total Liabilities $128.17M $122.20M $101.92M $92.32M $92.32M
Total Current Liabilities $110.23M $103.57M $83.27M $72.99M $72.99M
Payables $32.72M $22.90M $27.55M $20.29M $20.29M
-Accounts Payable $32.72M $22.90M $27.55M $20.29M $20.29M
Current Accrued Expenses $55.93M $65.06M $44.32M $32.10M $32.10M
Short-Term Debt and Capital Lease Obligation $3.85M $3.55M $3.18M $3.39M $3.39M
-Current Capital Lease Obligation $3.85M $3.55M $3.18M $3.39M $3.39M
Other Current Liabilities $1.83M $2.62M $1.15M $2.28M $2.28M
Total Non-Current Liabilities $17.94M $18.64M $18.66M $19.33M $19.33M
Long Term Debt and Capital Lease Obligation $16.13M $16.83M $16.86M $17.50M $17.50M
-Long Term Capital Lease Obligation $16.13M $16.83M $16.86M $17.50M $17.50M
Other Non-Current Liabilities $1.81M $1.80M $1.80M $1.83M $1.83M
Total Equity $564.68M $629.98M $545.93M $658.86M $658.86M
Stockholders' Equity $564.68M $629.98M $545.93M $658.86M $658.86M
Capital Stock $8.00M $7.93M $7.76M $7.75M $7.75M
-Common Stock $8.00M $7.93M $7.76M $7.75M $7.75M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $3.47B $3.32B $3.02B $2.95B $2.95B
Retained Earnings -$2.91B -$2.70B -$2.48B -$2.29B -$2.29B
Gains/Losses Not Affecting Retained Earnings -$2.70M -$2.67M -$2.63M -$2.54M -$2.54M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$159.81M -$141.12M -$122.29M -$322.93M -$101.94M
Net cash flow from continuing operations -$159.81M -$141.12M -$122.29M -$322.93M -$101.94M
Net Income from Continuing Operations -$208.39M -$215.70M -$189.42M -$1.08B -$219.17M
Gain/Loss from Continuing Operations $10,000.00 $30,000.00 $190,000.00 -$320,000.00 $94,000.00
Depreciation & Depletion & Amortization $85,000.00 $46,000.00 $44,000.00 $146,000.00 $42,000.00
Change in Working Capital $4.73M $8.76M -$1.68M $31.42M $8.34M
-Change in Prepaid Assets -$1.04M -$12.03M -$11.01M $4.87M $1.21M
-Change in Payables and Accrued Expense $6.72M $19.20M $11.17M $31.14M $7.34M
-Change in Other Current Assets -$510,000.00 -$217,000.00 -$1.03M -$4.88M -$347,000.00
-Change in Other Current Liabilities -$788,000.00 $1.48M -$1.17M $80,000.00 -$136,000.00
-Change In Other Working Capital $350,000.00 $335,000.00 $365,000.00 $203,000.00 $267,000.00
Net cash flow from investing -$204.16M $222.90M -$238,000.00 -$174.31M -$485.16M
Net Cash Flow from Continuing Investing Activities -$204.16M $222.90M -$238,000.00 -$174.31M -$485.16M
Net PPE Purchase and Sale -$396,000.00 -$909,000.00 -$245,000.00 -$657,000.00 -$164,000.00
Net Investment Purchase and Sale -$203.77M $223.81M $7,000.00 -$173.65M -$484.99M
Financing Cash Flow $95.43M $231.08M $3.80M $617.53M $573.82M
Net Cash Flow from Continuing Financing Activities $95.43M $231.08M $3.80M $617.53M $573.82M
Net Common Stock Issuance $92.83M – – $604.57M $572.80M
Proceeds from Stock Option Exercised $2.60M $3.67M $3.80M $12.97M $1.02M
Ending Cash Balance $151.13M $419.68M $106.83M $225.58M $225.58M
Net Change in Cash -$268.55M $312.85M -$118.73M $120.29M -$13.27M
Beginning Cash Balance $419.68M $106.83M $225.58M $105.19M $238.88M
Effect of Exchange Rate Changes -$9,000.00 $1,000.00 -$19,000.00 $102,000.00 -$19,000.00
Free Cash Flow -$160.21M -$142.03M -$122.54M -$323.59M -$102.10M
Net Issuance Payments Of Debt – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on SMMT.

Sign in to join the discussion.

Scroll to Top